Bulletin 19 - COVID Vaccine

Written on 05/10/2021
findsinead


Dear All,

Welcome to the COVID-19 bulletin (number 19) from the HSE National Immunisation Office which highlights changes in clinical guidance for the COVID-19 vaccination programme.

 

In this edition we cover

  •        Checking previous vaccination before administering a COVID-19 vaccine.
  •        Vaccines used in the COVID-19 immunisation programme
  •        COVID-19 vaccines for people with pre-existing allergies.
  •        Vaccination of people taking Methotrexate
  •        Amárach public opinion surveys on COVID-19 and COVID-19 vaccines:
  •        Vaccine safety monitoring
  •    Safety of COVID-19 vaccine Janssen® from US CDC
  •    Anxiety-Related Adverse Event Clusters after COVID-19 Vaccine Janssen® Vaccination in the US
  •    Latest vaccine safety monitoring report from the UK
  •        Latest from Research
  •    Data on effectiveness from Israel following national roll-out of Pfizer-BioNTech COVID-19 vaccine.
  •    Impact of Pfizer-BioNTech COVID-19 vaccine on variants (B.1.1.7 and B.1.351)
  •    Immune response following 1 dose of Pfizer-BioNTech COVID-19 vaccine
  •        HSELand COVID-19 Vaccination Programme
  •        Website
  •        Do you have queries?

 

We are looking for some feedback for our bulletin and other COVID-19 materials please complete our short survey.

We also recommend you visit our website regularly to ensure you have access to the most up to date guidelines and other documents.  

Finally a reminder bulletins will be published every week or more frequently, if required.

 

 

 

National Immunisation Office